Oklahoma City, OK30+ days ago
With an annual budget of about $100 million, more than 50 principal investigators, and a strong record of funding from the National Institutes of Health, technology transfer, and philanthropy, OMRF offers a stable and supportive environment for basic and translational research. Building scientific bridges between cancer biology and related disciplines such as aging, immune dysregulation, inflammation, genetics and epigenetics, cardiovascular biology, or autoimmunity, especially with relationship to long-term consequences of cancer treatments.